Returns as of 07/31/2020. The company will not receive any proceeds from the sale of the shares that are being offered by the stockholders.This slump may present an opportunity for interested investors to purchase shares of Zynex. Zynex's stock was trading at $11.09 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.According to analysts' consensus price target of $26.38, Zynex has a potential upside of 39.8% from its current price of $18.87.Zynex does not currently pay a dividend.Please log in to your account or sign up in order to add this asset to your watchlist.Zynex has only been the subject of 4 research reports in the past 90 days.The P/E ratio of Zynex is 85.77, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.01.One share of ZYXI stock can currently be purchased for approximately $18.87.In the past three months, Zynex insiders have sold 55,461.17% more of their company's stock than they have bought. View which stocks are hot on social media with MarketBeat's trending stocks report.Zynex trades on the OTCMKTS under the ticker symbol "ZYXI."
Stock Information; Presentations, Events and Webcasts; Research & Analysis; Contact placeholder; Stock Information. View which stocks have been most impacted by Coronavirus. See what's happening in the market right now with MarketBeat's real-time news feed.
The company is granting underwriters a 30-day option to acquire an additional 187,500 shares, while the stockholders participating in this transaction are also giving underwriters the option of buying 187,500 of their shares of common stock.Stock Advisor launched in February of 2002. NASDAQ Updated Jul 28, 2020 11:52 PM Zynex expects to raise $27.5 million (in gross proceeds) through this offering of common stock, which should close by July 17. Zynex Inc. ZYXI 18.80 0.71 (3.56%). Click here to read our press releases. Since then, ZYXI stock has increased by 75.9% and is now trading at $19.51. The company issued revenue guidance of $22.3-22.8 million, compared to the consensus revenue estimate of $22.06 million.Zynex has received 55.39% “outperform” votes from our community.You have already added five stocks to your watchlist. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.The P/E ratio of Zynex is 85.77, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.87.Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.Identify stocks that meet your criteria using seven unique stock screeners. Note that half of these shares are being sold directly by Zynex, while the remaining shares are being sold by certain stockholders.
The company's business has been picking up steam since several states have started reopening their economies. Export data to Excel for your own analysis.Zynex issued an update on its third quarter 2020After-Hours earnings guidance on Tuesday, July, 28th. Learn about financial terms, types of investments, trading strategies and more.Looking for new stock ideas? Want to see which stocks are moving? As such, Zynex's second-quarter financial results should be strong, and could help the company recover from today's losses.Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.Zynex expects to sell 2.5 million shares for $22 per share in this public offering of common stock.